VF
LENZ

Virtu Financial’s LENZ Therapeutics LENZ Stock Holding History

Virtu Financial’s Portfolio LENZ Stock Details LENZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$124K Sell
21,899
-16,621
-43% -$134K ﹤0.01% 1064
2026
Q1 		$352K Buy
38,520
+26,173
+212% +$368K 0.01% 738
2025
Q4 		$198K Buy
+12,347
New +$360K 0.01% 1028
2024
Q1 		– Sell
-4,985
Closed -$91K – 2202
2023
Q4 		$91K Buy
+4,985
New +$82.3K 0.01% 1050
2021
Q3 		– Sell
-1,101
Closed -$237K – 2041
2021
Q2 		$237K Buy
+1,101
New +$192K 0.02% 872

Other funds holding LENZ

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
AWG
Alpha Wave Global New York $6.24B AUM 59.73% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $163M AUM 240.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Squarepoint
Squarepoint New York $90.5B AUM 33.95% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
7IH
72 Investment Holdings Stamford, Connecticut $50M AUM 647.58% 1-Year Est. Return

Virtu Financial's LENZ Position: Q2 2026 in Review

Virtu Financial reduced its LENZ Therapeutics (LENZ) stake by 43% in Q2 2026, selling an estimated $134K and leaving 21,899 shares worth $124K. The position accounts for ﹤0.01% of the portfolio, ranked #1064.

Virtu Financial first reported a position in LENZ in Q2 2021 and has held it in 5 quarters since. The position peaked at $352K in Q1 2026. 145 funds tracked by Wall St. Rank hold LENZ as of Q2 2026.

  • Virtu Financial held 21,899 shares of LENZ Therapeutics worth $124K as of Q2 2026.
  • Virtu Financial sold 16,621 LENZ Therapeutics shares in Q2 2026, an estimated $134K.
  • LENZ Therapeutics made up ﹤0.01% of Virtu Financial's portfolio in Q2 2026, its #1064 holding.
  • Virtu Financial first reported a position in LENZ Therapeutics in Q2 2021 and has held it in 5 quarters since.
  • Virtu Financial's LENZ Therapeutics position peaked at $352K in Q1 2026.
  • 145 funds tracked by Wall St. Rank held LENZ Therapeutics as of Q2 2026.

Based on Virtu Financial's 13F filing for Q2 2026, filed 13 Aug 2026.